How long does it take to see the effects of taking Nilotinib?

Nilotinib (Nilotinib) is indicated for the treatment of patients with newly diagnosed chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+CML) and for the treatment of patients with chronic-phase and accelerated-phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+CML) who are resistant or intolerant to prior therapies, including imatinib. Nilotinib is used to reduce the symptoms or prevent the occurrence of chronic myelogenous leukemia (CML). Nilotinib is not usually a cure and often needs to be taken for many years to prevent chronic myelogenous leukemia from progressing to a more aggressive stage. After a year or several years of taking it, all symptoms of Chlorotropin may become unnoticeable.